Home / Blog – MesotheliomaHelp.org / Early Results of Mesothelioma Immuno-oncology Clinical Trial “Encouraging”

Early Results of Mesothelioma Immuno-oncology Clinical Trial “Encouraging”

In November, 2016, MesotheliomaHelp reported about the start of a mesothelioma clinical trial testing the efficacy of ONCOS-102, an immuno-oncology therapy,  when used in combination with chemotherapy drugs. Now, 18 months later, the researchers report “encouraging results” from the phase I/II trial. The clinical trial, being conducted at the Hospital Universitario Quirón in Barcelona, Spain, assessed the safety and “immunological activation” of the combination of ONCOS-102 with the chemotherapy combination of pemetrexed/cisplatin, the standard of care for pleural mesothelioma, according to a May 2 press release from Targovax, makers of the anti-cancer treatment. In the six-patient safety lead-in cohort, half […]

The post Early Results of Mesothelioma Immuno-oncology Clinical Trial “Encouraging” appeared first on MesotheliomaHelp.org.



from Blog – MesotheliomaHelp.org https://ift.tt/2G0KFYV
via IFTTT
Early Results of Mesothelioma Immuno-oncology Clinical Trial “Encouraging” Early Results of Mesothelioma Immuno-oncology Clinical Trial “Encouraging” Reviewed by Unknown on May 10, 2018 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.